Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson’s Disease and identifies clear opportunities to improve treatment options
A new study is the first to examine the application of behavioural science in getting underused therapies for Parkinson's Disease to the patients who need them most. https://mma.prnewswire.com/media/2719891/Alpharmaxim.jpg Parkinson's is widely considered to be one of the greatest challenges in medicine. With no cure currently available, treatment options are limited not just by local availability, […]